API Product Detail
Home API Terazosin CS-O-02479

Terazosin Hydrochloride

Chemical Properties and Information

Product Code: CS-O-02479 API
Terazosin Hydrochloride
API Family
Terazosin
Product Code
CS-O-02479

Terazosin Hydrochloride

Terazosin API
Stock Status: In Stock
Live

CAT No.
CS-O-02479
CAS No.
63074-08-8
Molecular Formula
C₁₉H₂₆ClN₅O₄
Molecular Weight
423.89
Login to view price
There is no hazardous surcharge associated with this product.
There is no packaging charge associated with this product.
For Research Purposes only. Not for Personal use.
All compounds supplied are strictly intended for laboratory, research, analytical, and scientific use only. They are not meant for human consumption, therapeutic use, or any form of clinical application.
CAS No.
63074-08-8
Product Code
CS-O-02479
M.F.
C₁₉H₂₆ClN₅O₄
M.W.
423.89
Smiles
NC1=NC(N2CCN(C(C3CCCO3)=O)CC2)=NC4=CC(OC)=C(OC)C=C14.Cl
Category
API
API Family
Terazosin
Storage Condition
Store at refrigerator (2-8°C) for long term storage
IUPAC Name
1-(4-Amino-6,7-dimethoxy-2-quinazolinyl)-4-[(tetrahydro-2-furanyl)carbonxyl]piperazine Hydrochloride
References
"Kycl (1986) Pharmcology of terazosin, Am,J,Med, 80 12, Maruyama et al (1994)comparison of displcemental potecies of terazosin enantiomers for a1-adrenceptor subtypes, Biol,Pharm,Bull, 17 1126, Hacck et al (1995) ctions of terazosin and its enantiomers at subtypes of a1- and a2-adrenceptors in vitro, J,Rc,Signal Transdct,Res, 15 863,"
Synonyms
Terazosin HCl
Application Notes
"Terazosin is used to treat hypertension (high blood pressure), or to improve urination in men with benign prostatic hyperplasia (enlarged prostate)."
Purity by HPLC
>98%
Hazard Compound
Refer MSDS for complete information.
Overview
"Terazosin is used to treat hypertension (high blood pressure), or to improve urination in men with benign prostatic hyperplasia (enlarged prostate)."
Downloading MSDS…
Quick Enquiry
Tell us what you need
Quote Basket
Selected RFQ Items
Your RFQ basket is empty. Add a product block or copy a guided requirement here.